融捷健康因会计核算等多项违规收安徽证监局责令改正措施

Core Viewpoint - Rongjie Health Technology Co., Ltd. has received an administrative regulatory measure from the Anhui Securities Regulatory Bureau due to issues related to accounting irregularities, inaccurate information disclosure, and improper use of raised funds [1][2]. Group 1: Accounting Irregularities - The company has been found to have accounting irregularities, particularly in revenue recognition, where sales are recognized at the point of shipment, inconsistent with the revenue recognition policy disclosed in the annual report [1]. - The consolidated financial statements did not write off the revaluation surplus of investment properties held by subsidiaries, leading to an inflated balance of 2.2509 million yuan in the "Investment Properties" account for the years 2022-2024 [1]. Group 2: Inaccurate Information Disclosure - The company’s 2024 annual report and financial statement notes contain multiple errors and omissions, including inconsistencies in the amounts disclosed for "assets and liabilities measured at fair value" and inaccuracies in the disclosure of "foreign currency monetary items" [2]. - There were also discrepancies in the reported reduction amounts for "fixed assets - office and other equipment" and failure to disclose changes in accounting estimates for "other receivables" as required [2]. Group 3: Improper Use of Raised Funds - The company has been cited for improper use of raised funds and inaccurate related disclosures, violating regulatory requirements outlined in the "Guidelines for the Management and Use of Raised Funds by Listed Companies" [2]. - The Anhui Securities Regulatory Bureau has mandated the company to rectify these issues within 30 days of receiving the decision and submit a written report [2].